Weiss Multi-Strategy Advisers LLC - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 222 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.18 and the average weighting 0.3%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2020$496,000
-21.3%
10,353
+3.5%
0.01%
-44.0%
Q1 2020$630,000
-49.2%
10,0000.0%0.02%
+25.0%
Q4 2019$1,239,000
+33.4%
10,000
-28.6%
0.02%
+5.3%
Q3 2019$929,000
-10.2%
14,000
+7.7%
0.02%
-29.6%
Q2 2019$1,034,000
-28.9%
13,0000.0%0.03%
-25.0%
Q1 2019$1,454,000
+570.0%
13,000
+550.0%
0.04%
+227.3%
Q4 2016$217,000
-34.0%
2,0000.0%0.01%
-45.0%
Q3 2016$329,000
+26.5%
2,000
+9.7%
0.02%0.0%
Q2 2016$260,000
-74.7%
1,823
-77.2%
0.02%
-55.6%
Q1 2016$1,028,000
-23.5%
8,000
-11.1%
0.04%
-51.6%
Q4 2015$1,344,000
-37.7%
9,000
-30.8%
0.09%
-2.1%
Q3 2015$2,156,000
-55.3%
13,000
-35.0%
0.10%
-50.3%
Q2 2015$4,828,000
-31.5%
20,000
-20.0%
0.19%
-39.0%
Q1 2015$7,051,000
+66.8%
25,000
-7.7%
0.31%
+114.4%
Q4 2014$4,228,000
-34.6%
27,100
-0.7%
0.15%
-7.6%
Q3 2014$6,462,000
+5.0%
27,300
+5.0%
0.16%
+17.9%
Q2 2014$6,152,000
-36.1%
26,000
-11.0%
0.13%
-30.9%
Q1 2014$9,630,000
+125.6%
29,200
-53.3%
0.19%
+110.9%
Q4 2013$4,268,000
-22.7%
62,500
-21.9%
0.09%
+55.9%
Q3 2013$5,522,000
+207.8%
80,000
+100.0%
0.06%
+13.5%
Q2 2013$1,794,00040,0000.05%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders